Baxter International (NYSE:BAX) was trucking along in 2019, with shares climbing steadily. The company beat analysts' estimates with its second-quarter results and even boosted its full-year outlook. But the good times have come to a screeching halt.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,